Nestlé Health Science to acquire Aimmune in US$2.6 billion move

The aim is to boost Nestlé Health Science’s food allergy treatment foothold

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

24 Feb 2021 --- Lesaffre is launching an offer to acquire all outstanding shares of NattoPharma. The offer values the total equity of the Norway-based vitamin K2 expert at NOK 631... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

19 Feb 2021 --- Despite COVID-19 headwinds, the pandemic did not slow Nestlé’s business down throughout 2020, a company spokesperson tells NutritionInsight, commenting... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

17 Feb 2021 --- Kerry Group has announced its intention of acquiring Spain-based Biosearch Life. The acquisition is set to be completed by means of a “friendly public tender... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

12 Feb 2021 --- This week in nutrition news, US-based digital fitness streaming and nutrition solutions provider Beachbody Company announced it would be going public by entering... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

04 Feb 2021 --- Nestlé Health Science (NHSc) has teamed up with various cereal brands to launch a line of flavors for Carnation Breakfast Essentials Nutritional Drinks. A... Read More

trans